Emo Capital Corp.
NUVI · OTC
7/31/2025 | 7/31/2024 | 7/31/2023 | 7/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 1.40 | 0.04 | 0.00 | 0.00 |
| FCF Yield | -0.07% | -0.00% | -0.00% | 0.00% |
| EV / EBITDA | 4.61 | -2.07 | -6.62 | 0.00 |
| Quality | ||||
| ROIC | 0.01% | 1,157.47% | 1,927.19% | 2.72% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.01 | 0.02 | 0.04 | – |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | -100.00% |
| Free Cash Flow Growth | 58.33% | 57.85% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 3.26 | -0.04 | -0.09 | 0.00 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |